Skip to content
10-K

Annual Report

REGENERON PHARMACEUTICALS, INC. REGN

0000872589-26-000008

← back to feed
Filed
Feb 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 108.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 115.1M sh
Shares Diluted FY 2025 · Dec 31, 2023 113.7M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $3.44B
Stock Repurchased FY 2025 · Dec 31, 2024 $2.6B
Stock Repurchased FY 2025 · Dec 31, 2023 $2.24B
Dividends Paid FY 2025 · Dec 31, 2025 $370.3M
Dividends Paid FY 2025 · Dec 31, 2024 $0
Dividends Paid FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $898.4M
Capex FY 2025 · Dec 31, 2024 $755.9M
Capex FY 2025 · Dec 31, 2023 $718.6M
Operating Cash Flow FY 2025 · Dec 31, 2025 $4.98B
Operating Cash Flow FY 2025 · Dec 31, 2024 $4.42B
Operating Cash Flow FY 2025 · Dec 31, 2023 $4.59B
Long Term Debt FY 2025 · Dec 31, 2025 $1.99B
Long Term Debt FY 2025 · Dec 31, 2024 $1.98B
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.12B
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.49B
Cash And Equivalents FY 2025 · Dec 31, 2023 $2.73B
Stockholders Equity FY 2025 · Dec 31, 2025 $31.26B
Stockholders Equity FY 2025 · Dec 31, 2024 $29.35B
Stockholders Equity FY 2025 · Dec 31, 2023 $25.97B
Stockholders Equity FY 2025 · Dec 31, 2022 $22.66B
Current Liabilities FY 2025 · Dec 31, 2025 $4.37B
Current Liabilities FY 2025 · Dec 31, 2024 $3.94B
Total Liabilities FY 2025 · Dec 31, 2025 $9.3B
Total Liabilities FY 2025 · Dec 31, 2024 $8.41B
Current Assets FY 2025 · Dec 31, 2025 $18.02B
Current Assets FY 2025 · Dec 31, 2024 $18.66B
Total Assets FY 2025 · Dec 31, 2025 $40.56B
Total Assets FY 2025 · Dec 31, 2024 $37.76B
Eps Diluted FY 2025 · Dec 31, 2025 $41.48
Eps Diluted FY 2025 · Dec 31, 2024 $38.34
Eps Diluted FY 2025 · Dec 31, 2023 $34.77
Eps Basic FY 2025 · Dec 31, 2025 $43.07
Eps Basic FY 2025 · Dec 31, 2024 $40.90
Eps Basic FY 2025 · Dec 31, 2023 $37.05
Sga Expense FY 2025 · Dec 31, 2025 $2.7B
Sga Expense FY 2025 · Dec 31, 2024 $2.95B
Sga Expense FY 2025 · Dec 31, 2023 $2.63B
Rd Expense FY 2025 · Dec 31, 2025 $5.85B
Rd Expense FY 2025 · Dec 31, 2024 $5.13B
Rd Expense FY 2025 · Dec 31, 2023 $4.44B
Net Income FY 2025 · Dec 31, 2025 $4.5B
Net Income FY 2025 · Dec 31, 2024 $4.41B
Net Income FY 2025 · Dec 31, 2023 $3.95B
Operating Income FY 2025 · Dec 31, 2025 $3.58B
Operating Income FY 2025 · Dec 31, 2024 $3.99B
Operating Income FY 2025 · Dec 31, 2023 $4.05B
Revenue FY 2025 · Dec 31, 2025 $14.34B
Revenue FY 2025 · Dec 31, 2024 $14.2B
Revenue FY 2025 · Dec 31, 2023 $13.12B